Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MSeres Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

Seres Therapeutics, Inc.

$4.02Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $736K. Net result $4.58M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $736K. Running result $736K. Revenue: $736K.
  • Cost of revenue: $0. Running result $736K.
  • Gross profit: $736K. Running result $736K.
  • Research and development expenses: −$9.14M. Running result −$8.41M.
  • General and administrative expenses: −$7.06M. Running result −$15.47M.
  • Impairment of long-lived assets: −$5.81M. Running result −$21.27M.
  • Manufacturing services: $0. Running result −$21.27M.
  • Operating income: −$21.27M. Running result −$21.27M.
  • Other income: $25.85M. Running result $4.58M.
  • Pre-tax income: $4.58M. Running result $4.58M.
  • Income tax benefit: $0. Running result $4.58M.
  • Net income: $4.58M. Running result $4.58M.